Monday, August 28, 2017

Gilead to buy Kite Pharma for about $11.9 billion in cash

Gilead Sciences on Monday agreed to buy Kite Pharma for about $11.9 billion in cash, Dow Jones reported, citing sources.

from Mergers and Acquisitions http://ift.tt/2vCrlw3

No comments:

Post a Comment